AMELIORATION OF CHRONIC ANTHRACYCLINE CARDIOTOXICITY BY ICRF-187 AND OTHER COMPOUNDS

被引：30

作者：

HERMAN, EH ^{[1
]}

FERRANS, VJ ^{[1
]}

机构：

[1] NHLBI,PATHOL BRANCH,BETHESDA,MD 20892

来源：

CANCER TREATMENT REVIEWS | 1987年 / 14卷 / 3-4期

关键词：

D O I：

10.1016/0305-7372(87)90011-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：225 / 229

页数：5

共 18 条

[1]

BACHUR NR, 1977, MOL PHARMACOL, V13, P901

[2]

BREED JGS, 1980, CANCER RES, V40, P2033

[3]

BRISTOW MR, 1978, CANCER TREAT REP, V62, P873

[4] PREVENTION OF DOXORUBICIN CARDIAC TOXICITY IN THE MOUSE BY N-ACETYLCYSTEINE [J].

DOROSHOW, JH ;

LOCKER, GY ;

IFRIM, I ;

MYERS, CE .

JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) :1053-1064

[5] ENZYMATIC DEFENSES OF THE MOUSE HEART AGAINST REACTIVE OXYGEN METABOLITES - ALTERATIONS PRODUCED BY DOXORUBICIN [J].

DOROSHOW, JH ;

LOCKER, GY ;

MYERS, CE .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (01) :128-135

[6] EFFECT OF SULFHYDRYL-CONTAINING COMPOUNDS ON THE ANTI-TUMOR EFFECTS OF ADRIAMYCIN [J].

FREEMAN, RW ;

MACDONALD, JS ;

OLSON, RD ;

BOERTH, RC ;

OATES, JA ;

HARBISON, RD .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1980, 54 (01) :168-175

[7]

HERMAN E, 1979, CANCER TREAT REP, V63, P89

[8]

HERMAN EH, 1981, CANCER RES, V41, P3436

[9]

HERMAN EH, 1981, RES COMMUN CHEM PATH, V31, P85

[10]

LEFRAK EA, 1975, CANCER CHEMOTH REP 3, V6, P203

← 1 2 →